Halozyme Therapeutics, Inc.

Skandinaviska Enskilda Banken AB (publ) HALO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

34,700

Value ($000)

2,335

Weight

0.0%

2020 Q2 - 2025 Q4 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	2,335	0.0%	34,700	12/31/2025
2025 Q3	11/7/2025	2,736	0.0%	37,300	9/30/2025
2025 Q2	8/13/2025	2,652	0.0%	51,000	6/30/2025
2025 Q1	5/7/2025	4,331	0.0%	67,900	3/31/2025
2024 Q4	2/10/2025	1,541	0.0%	32,100	12/31/2024
2024 Q3	11/7/2024	2,725	0.0%	47,627	9/30/2024
2024 Q2	8/13/2024	49	0.0%	927	6/30/2024
2023 Q2	8/7/2023	400	0.0%	11,087	6/30/2023
2023 Q1	5/11/2023	614	0.0%	16,087	3/31/2023
2022 Q4	2/8/2023	659	0.0%	11,581	12/31/2022
2022 Q3	11/14/2022	1,217	0.0%	30,774	9/30/2022
2022 Q2	8/10/2022	2,350	0.0%	53,398	6/30/2022
2022 Q1	5/11/2022	2,130	0.0%	53,398	3/31/2022
2021 Q4	2/10/2022	13,027	0.1%	323,083	12/31/2021
2021 Q3	11/10/2021	14,006	0.1%	344,302	9/30/2021
2021 Q2	8/10/2021	8,887	0.1%	195,714	6/30/2021
2021 Q1	5/14/2021	8,159	0.1%	195,714	3/31/2021
2020 Q4	2/11/2021	2,610	0.0%	61,100	12/31/2020
2020 Q3	11/12/2020	2,118	0.0%	80,600	9/30/2020
2020 Q2	8/13/2020	866	0.0%	32,300	6/30/2020